Pharmaxis Builds Senior Management Team

17th Feb 09

Release Date: 17/02/2009 12:00am

Pharmaceutical company Pharmaxis (ASX:PXS, Nasdaq:PXSL) today announced that it had appointed Dr Howard Fox to its senior management team in the position of Chief Medical Officer. Dr Fox will assume responsibility for regulatory affairs, pharmacovigilance and medical affairs. Clinical Operations will continue to report to the Medical Director, Dr Brett Charlton.

View PDF